SIA
PROK icon

Schechter Investment Advisors’s ProKidney PROK Stock Holding History

Schechter Investment Advisors’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-285,950
Closed -$2.85M – 979
2022
Q2 		$2.85M Sell
285,950
-9,150
-3% -$90.5K 0.28% 53
2022
Q1 		$2.92M Buy
295,100
+257,847
+692% +$2.54M 0.27% 57
2021
Q4 		$369K Buy
+37,253
New +$368K 0.03% 609

Other funds holding PROK

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Schechter Investment Advisors's PROK Position: Q3 2022 in Review

Schechter Investment Advisors sold out of ProKidney (PROK) in Q3 2022, closing a stake of 285,950 shares — an estimated $2.85M sold.

Schechter Investment Advisors first reported a position in PROK in Q4 2021 and held it in 3 quarters. The position peaked at $2.92M in Q1 2022. 18 funds tracked by Wall St. Rank hold PROK as of Q3 2022.

  • Schechter Investment Advisors reported no remaining ProKidney position as of Q3 2022 after selling out during the quarter.
  • Schechter Investment Advisors sold 285,950 ProKidney shares in Q3 2022, an estimated $2.85M.
  • Schechter Investment Advisors first reported a position in ProKidney in Q4 2021 and held it in 3 quarters.
  • Schechter Investment Advisors's ProKidney position peaked at $2.92M in Q1 2022.
  • 18 funds tracked by Wall St. Rank held ProKidney as of Q3 2022.

Based on Schechter Investment Advisors's 13F filing for Q3 2022, filed 4 Nov 2022.